| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0072-9752(07)01266-3 |
| P698 | PubMed publication ID | 18631792 |
| P2093 | author name string | Inga Zerr | |
| P2860 | cites work | Akinetic mutism as a classification criterion for the diagnosis of Creutzfeldt-Jakob disease | Q24680088 |
| Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene | Q28181555 | ||
| Familial and sporadic fatal insomnia | Q28185765 | ||
| Mutations of the prion protein gene phenotypic spectrum | Q28214069 | ||
| Gerstmann-Sträussler-Scheinker syndrome,fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies | Q28215151 | ||
| Transmission dynamics and epidemiology of BSE in British cattle | Q28286643 | ||
| Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease | Q28366081 | ||
| How to improve the clinical diagnosis of Creutzfeldt-Jakob disease | Q30584961 | ||
| The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease | Q30594575 | ||
| Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests | Q30698122 | ||
| Generalised periodic epileptiform discharges: clinical features, neuroradiological evaluation and prognosis in 37 adult patients | Q30824676 | ||
| Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease | Q30951764 | ||
| Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. | Q30983435 | ||
| Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease. | Q31099384 | ||
| 14-3-3 protein cerebrospinal fluid detection in human growth hormone-treated Creutzfeldt-Jakob disease patients | Q32061201 | ||
| Single photon emission computed tomography in the identification of new variant Creutzfeldt-Jakob disease: case reports | Q33756442 | ||
| Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent | Q33805383 | ||
| Prion protein conformation in a patient with sporadic fatal insomnia | Q33863178 | ||
| Iatrogenic Creutzfeldt-Jakob disease at the millennium. | Q33924749 | ||
| Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease | Q33933969 | ||
| Unconventional Viruses and the Origin and Disappearance of Kuru | Q34258483 | ||
| Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates | Q34275181 | ||
| A new variant of Creutzfeldt-Jakob disease in the UK. | Q34374893 | ||
| Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. | Q34403513 | ||
| Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease | Q34797150 | ||
| Kuru: the old epidemic in a new mirror | Q34882018 | ||
| Transmission of prions. | Q34993067 | ||
| Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-- Jakob disease: implications for human health | Q35057650 | ||
| Hereditary Creutzfeldt-Jakob disease and fatal familial insomnia. | Q35122319 | ||
| Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2 | Q35453792 | ||
| Changing Patterns of Kuru: Epidemiological Changes in the Period of Increasing Contact of the Fore People with Western Civilization | Q47792880 | ||
| Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias | Q48010180 | ||
| Results of quinacrine administration to patients with Creutzfeldt-Jakob disease | Q48087933 | ||
| Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease | Q48126727 | ||
| Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease | Q48135774 | ||
| Reliability of EEG in the diagnosis of Creutzfeldt-Jakob disease | Q48137105 | ||
| Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease | Q48152236 | ||
| Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance | Q48181910 | ||
| Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. | Q48263573 | ||
| Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. | Q48297442 | ||
| Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease | Q48298019 | ||
| Phenotypic variability in fatal familial insomnia (D178N-129M) genotype | Q48349371 | ||
| High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease | Q48419470 | ||
| Familial Creutzfeldt-Jakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20. | Q48420015 | ||
| SPECT in the early diagnosis of Creutzfeldt-Jakob disease | Q48485572 | ||
| Creutzfeldt-Jakob disease in a husband and wife | Q48499224 | ||
| Clinical changes and EEG patterns preceding the onset of periodic sharp wave complexes in Creutzfeldt-Jakob disease. | Q48501450 | ||
| Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. | Q48521519 | ||
| Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD. | Q48525187 | ||
| Ataxic Creutzfeldt-Jakob disease: diagnostic techniques and neuropathologic observations in early disease | Q48529603 | ||
| Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease | Q48550821 | ||
| Focal involvement and lateralization in Creutzfeldt-Jakob disease: correlation of clinical, electroencephalographic and neuropathological findings | Q48573132 | ||
| Brain magnetic resonance diffusion abnormalities in Creutzfeldt-Jakob disease | Q48597877 | ||
| Sequential MRI in a case of Creutzfeldt-Jakob disease | Q48635798 | ||
| Cerebral metabolism in fatal familial insomnia: relation to duration, neuropathology, and distribution of protease-resistant prion protein | Q48672330 | ||
| MRI evidence of cerebellar and hippocampal involvement in Creutzfeldt-Jakob disease | Q48756671 | ||
| Bovine spongiform encephalopathy: epidemiological studies on the origin | Q48770901 | ||
| Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles | Q48810520 | ||
| MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement | Q48852997 | ||
| [18F]FDG PET in fatal familial insomnia: the functional effects of thalamic lesions | Q48857516 | ||
| The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies | Q48913771 | ||
| Diffusion-weighted MRI in familial Creutzfeldt-Jakob disease with the codon 200 mutation in the prion protein gene | Q48916780 | ||
| Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI. | Q48957896 | ||
| Brain SPECT of Creutzfeldt-Jakob disease | Q49075707 | ||
| Generalized Cortico-Reticular Epilepsies Some Considerations on the Pathophysiology of Generalized Bilaterally Synchronous Spike and Wave Discharge | Q49154185 | ||
| Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease | Q49156381 | ||
| Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. | Q51037857 | ||
| [Correlation of diffusion-weighted magnetic resonance imaging with neurological deficits in sporadic Creutzfeldt-Jakob Disease] | Q52010732 | ||
| Focal-unilateral accentuation of changes observed in the early stage of Creutzfeldt-Jakob disease. | Q53035921 | ||
| Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. | Q53231720 | ||
| Heidenhain variant of Creutzfeldt-Jakob disease: diffusion-weighted MRI and PET characteristics. | Q53632929 | ||
| Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. | Q53888877 | ||
| 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients. | Q55475265 | ||
| Serial Diffusion-Weighted MRI of Creutzfeldt-Jakob Disease | Q56040087 | ||
| Creutzfeldt-Jakob disease cluster in an Australian rural city | Q57092926 | ||
| Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model | Q57092933 | ||
| Current clinical diagnosis in Creutzfeldt-Jakob disease: Identification of uncommon variants | Q57274037 | ||
| S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease | Q57274052 | ||
| Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease | Q57781094 | ||
| BSE transmission to macaques | Q59098670 | ||
| Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). | Q44059193 | ||
| Increased detection of 14-3-3 protein in cerebrospinal fluid in Sporadic Creutzfeldt-Jakob Disease during the disease course | Q44209375 | ||
| Clinical and radiological mimicry of vCJD in a valine homozygous PrP(Sc) type 1 sCJD patient | Q44449344 | ||
| Molecular classification of sporadic Creutzfeldt-Jakob disease. | Q44451927 | ||
| Creutzfeldt-Jakob disease via dural and corneal transplants | Q44494777 | ||
| Synthesis and evaluation of analogues of Congo red as potential compounds against transmissible spongiform encephalopathies | Q44495098 | ||
| Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent | Q44592404 | ||
| MR imaging of Creutzfeldt-Jakob disease | Q44637990 | ||
| CSF lactate dehydrogenase activity in patients with Creutzfeldt-Jakob disease exceeds that in other dementias | Q44739307 | ||
| Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study | Q44790692 | ||
| Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients | Q44795783 | ||
| Creutzfeldt-Jakob disease, Heidenhain variant: case report with MRI (DWI) findings | Q44965016 | ||
| A discrepancy between Tc-99m HMPAO SPECT and Tc-99m ECD SPECT in Creutzfeldt-Jacob disease | Q44984358 | ||
| Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting | Q45014753 | ||
| Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease | Q45023740 | ||
| Creutzfeldt-Jakob disease and homocysteine levels in plasma and cerebrospinal fluid | Q45265212 | ||
| Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families | Q45279178 | ||
| Immunoglobulins and virus-specific antibodies in patients with Creutzfeldt-Jakob disease | Q45515369 | ||
| Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type | Q46750178 | ||
| Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains | Q47244096 | ||
| Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. | Q47403963 | ||
| False-positive pulvinar sign on MRI in sporadic Creutzfeldt-Jakob disease | Q47779177 | ||
| Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease | Q35462665 | ||
| Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease? | Q35463972 | ||
| MRI characteristics of sporadic CJD with valine homozygosity at codon 129 of the prion protein gene and PrPSc type 2 in Japan | Q35479795 | ||
| The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease. | Q35486440 | ||
| Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment. | Q35560261 | ||
| 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins | Q35624026 | ||
| Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease | Q36197195 | ||
| Birth of a prion: spontaneous generation revisited | Q36211122 | ||
| Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96 | Q36245852 | ||
| Epidemiological surveillance of Creutzfeldt-Jakob disease in the United Kingdom | Q36870309 | ||
| Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets | Q36978208 | ||
| AN ATAXIC FORM OF SUBACUTE PRESENILE POLIOENCEPHALOPATHY (CREUTZFELDT-JAKOB DISEASE) | Q37122173 | ||
| Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models | Q37730189 | ||
| Diffusion-weighted magnetic resonance imaging in probable Creutzfeldt-Jakob disease: a clinical-anatomic correlation | Q38527524 | ||
| The question of clustering of Creutzfeldt-Jakob disease | Q38596713 | ||
| Analysis of the geographical distribution of sporadic Creutzfeldt-Jakob disease in France between 1992 and 1998. | Q38959007 | ||
| A mutation in the prion protein gene in Creutzfeldt-Jakob disease in Jewish patients of Libyan, Greek, and Tunisian origin | Q39145413 | ||
| A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of clustering. | Q39182406 | ||
| Familial Creutzfeldt-Jakob disease. Codon 200 prion disease in Libyan Jews | Q39241829 | ||
| Correlation between population density and the frequency of Creutzfeldt-Jakob disease in France | Q39342959 | ||
| Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. | Q40483672 | ||
| Neurologic genetic diseases of Jewish people | Q40594361 | ||
| Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD. | Q40855107 | ||
| Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells | Q40892763 | ||
| Letter: Hepatitis with hindsight | Q40905675 | ||
| Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering | Q41015587 | ||
| Epidemiologic comparisons between Creutzfeldt-Jakob disease and scrapie in France during the 12-year period 1968-1979. | Q41468226 | ||
| The Neuropsychiatric Inventory: assessing psychopathology in dementia patients | Q41471895 | ||
| Virus-induced electrotonic coupling: Hypothesis on the mechanism of periodic EEG discharges in Creutzfeldt-Jakob disease | Q41551995 | ||
| New variant Creutzfeldt-Jakob disease: psychiatric features | Q41604119 | ||
| The Heidenhain variant of Creutzfeldt-Jakob disease | Q42467154 | ||
| Sporadic Creutzfeldt-Jakob disease without dementia at onset: clinical features, laboratory tests and sequential diffusion MRI (in an autopsy-proven case). | Q42470714 | ||
| Creutzfeldt-Jakob disease: correlation of MRI and neuropathologic findings | Q42510326 | ||
| Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease | Q42630507 | ||
| Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease | Q42631333 | ||
| Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada | Q43218822 | ||
| Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease | Q43721327 | ||
| Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt-Jakob Disease phenotype | Q43783023 | ||
| Increased CSF levels of prostaglandin E(2) in variant Creutzfeldt-Jakob disease | Q43847881 | ||
| Early evolution and incidence of electroencephalographic abnormalities in Creutzfeldt-Jakob disease | Q43860274 | ||
| Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease | Q43863115 | ||
| 14-3-3 Protein isoforms and atypical patterns of the 14-3-3 assay in the diagnosis of Creutzfeldt-Jakob disease | Q43890002 | ||
| 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein | Q43975864 | ||
| The Effect of Amantadine on Arousal and EEG Patterns in Creutzfeldt-Jakob Disease | Q43998713 | ||
| Effects of the polyene antibiotic derivative MS-8209 on the astrocyte lysosomal system of scrapie-infected hamsters | Q44023828 | ||
| Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease | Q59505845 | ||
| Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects | Q59690387 | ||
| Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues | Q59691718 | ||
| Analysis of the exon 1 polymorphism in the Tau gene in transmissible spongiform encephalopathies | Q60042424 | ||
| Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease | Q62381837 | ||
| Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. | Q64960210 | ||
| Brain and CSF proteins in Creutzfeldt-Jakob disease. | Q64981747 | ||
| Focal EEG abnormalities in Heidenhain's variant of Jakob-Creutzfeldt disease | Q67298317 | ||
| Panencephalitic Creutzfeldt-Jakob disease. Unusual presentation of magnetic resonance imaging and proton magnetic resonance spectroscopy | Q71496737 | ||
| 18F-fluorodeoxyglucose-PET and 99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease | Q71550201 | ||
| Serial EEG findings in 27 cases of Creutzfeldt-Jakob disease | Q72126917 | ||
| Periodic lateralized epileptiform complexes (PLEDs) in Creutzfeldt-Jakob disease | Q72137438 | ||
| Human astrocyte production of tumour necrosis factor-alpha, interleukin-1 beta, and interleukin-6 following exposure to lipopolysaccharide endotoxin | Q72220670 | ||
| Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease | Q72256087 | ||
| Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease | Q72318725 | ||
| Failure to Modify Scrapie in Mice by Administration of Interferon or Anti-interferon Globulin | Q72698653 | ||
| Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt-Jakob disease | Q73317175 | ||
| [Diffusion-weighted MRI in patients with Creutzfeldt-Jakob disease] | Q73511398 | ||
| Diagnostic problems during late course in Creutzfeldt-Jakob disease | Q73546146 | ||
| Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates | Q73556100 | ||
| Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease | Q73556105 | ||
| Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease | Q73624596 | ||
| New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests | Q73742650 | ||
| A case of Creutzfeldt-Jakob disease with a point mutation at codon 232: correlation of MRI and neurologic findings | Q73884540 | ||
| Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease | Q74333080 | ||
| Identification in Israel of 2 Jewish Creutzfeld-Jakob disease patients with a 178 mutation at their PrP gene | Q74412478 | ||
| 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease | Q74587325 | ||
| Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study | Q74597673 | ||
| Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease | Q74614409 | ||
| Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls | Q74661685 | ||
| Genotype at codon 129 and susceptibility to Creutzfeldt-Jakob disease | Q74716080 | ||
| Decreased Levels of Amyloid-beta 1-42 in Cerebrospinal Fluid of Creutzfeldt-Jakob Disease Patients | Q74736589 | ||
| [Elecroencephalographic charactistics of Creutzfeldt-Jakob disease and its differential diagnosis] | Q77311491 | ||
| Glomus vagale presenting as a supraclavicular mass: magnetic resonance imaging findings | Q77617514 | ||
| Molecular genetics of transmissible spongiform encephalopathies | Q77732793 | ||
| Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies | Q77738553 | ||
| Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease | Q77769464 | ||
| Human prion diseases: cause, clinical and diagnostic aspects | Q79910538 | ||
| Magnetic resonance imaging findings in pre-clinical Creutzfeldt-Jakob disease | Q80417862 | ||
| Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings | Q80461405 | ||
| Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease | Q80790325 | ||
| Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease | Q81335017 | ||
| P921 | main subject | prion protein family | Q24724413 |
| P304 | page(s) | 737-764 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn | Q26842295 |
| P1476 | title | Clinical and therapeutic aspects of prion disease | |
| P478 | volume | 89 |
| Q104289351 | Epilepsy and prion diseases: A narrative review | cites work | P2860 |
Search more.